While China Pulls Ahead In Regenerative Medicine Research, Its Loosely Regulated Stem Cell Treatment Centers Raise International Concerns
This article was originally published in PharmAsia News
Executive Summary
BEIJING - China's ascendancy as a world power in regenerative medicine has been marked by a rapid-fire increase in the writing of top-level papers in the field for international scientific publications, but also by the appearance of controversial stem cell centers that sometimes offer treatments that have not been tested in clinical trials
You may also be interested in...
U.S.-based NeoStem Signs Twin Agreements To Provide Stem Cell Treatments To Chinese Hospitals
BEIJING - The New York-headquartered biopharmaceutical firm NeoStem Inc has signed twin agreements to provide a leading-edge stem cell-based orthopedic therapy to two Chinese hospitals
U.S.-based NeoStem Signs Twin Agreements To Provide Stem Cell Treatments To Chinese Hospitals
BEIJING - The New York-headquartered biopharmaceutical firm NeoStem Inc has signed twin agreements to provide a leading-edge stem cell-based orthopedic therapy to two Chinese hospitals
China Emerging As World Power In Stem Cell Research
BEIJING - China is speedily evolving into a global power in terms of stem cell research, with the central government stepping up funding and recruiting scientists worldwide in order to catapult the country into the advance ranks of regenerative medicine, according to four scholars at the University of Toronto